Table 2. Pregnancy-related complications, postpartum conditions, and laboratory tests of mothers infected with COVID-19.
| All mothers | Mothers whose child had COVID-19 | Mothers whose child had abnormal radiological findings without COVID-19 | Mothers whose child discharged after birth | |
|---|---|---|---|---|
| (n = 29) | (n = 5) | (n = 12) | (n = 12) | |
| No. (%) | No. (%) | No. (%) | No. (%) | |
| Pregnancy-related complications | ||||
| Gestational hypertensive disorder | 2 (6.90) | 0 (0.00) | 0 (0.00) | 2 (16.67) |
| Gestational diabetes mellitus | 3 (10.34) | 1 (20.00) | 0 (0.00) | 2 (16.67) |
| Gestational anemia | 3 (10.34) | 2 (40.00) | 1 (8.33) | 0 (0.00) |
| Preterm premature rupture of membranes | 5 (17.24) | 0 (0.00) | 1 (8.33) | 4 (33.33) |
| Fetal distress | 3 (10.34) | 0 (0.00) | 3 (25.00) | 0 (0.00) |
| Postpartum hemorrhage | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) |
| Other complications | 5 (17.24) | 2 (40.00) | 1 (8.33) | 2 (16.67) |
| Mode of delivery | ||||
| Vaginal | 2 (6.90) | 0 (0.00) | 2 (16.67) | 0 (0.00) |
| Cesarean section | 27 (93.10) | 5 (100.00) | 10 (83.33) | 12 (100.00) |
| Number of fetus | ||||
| Singleton | 28 (96.55) | 5 (100.00) | 11 (91.67) | 12 (100.00) |
| Twin | 1 (3.45) | 0 (0.00) | 1 (8.33) | 0 (0.00) |
| Gestational age at delivery, weeks | ||||
| 35–36 | 3 (10.34) | 0 (0.00) | 2 (16.67) | 1 (8.33) |
| 37–38 | 14 (48.28) | 3 (60.00) | 7 (58.33) | 4 (33.33) |
| 39–41 | 12 (41.38) | 2 (40.00) | 3 (25.00) | 7 (58.33) |
| White blood cell count, median (IQR), ×109/L | 8.68 (3.32) | 7.63 (3.35) | 8.47 (4.96) | 9.14 (2.28) |
| Lymphocyte count, median (IQR), ×109/L | 1.35 (0.69) | 1.31 (0.76) | 1.38 (0.57) | 1.24 (0.60) |
| Lymphocyte percentage, median (IQR), % | 15.35 (10.22) | 16.65 (11.02) | 15.65 (11.91) | 15.05 (7.39) |
| C-reactive protein, median (IQR), mg/L | 22.20 (36.39) | 52.00 (78.83) | 16.00 (32.00) | 24.70 (28.99) |
Data are presented as the median (IQR) or frequency (proportion).
COVID-19, coronavirus disease 2019.